Our AgTech portfolio company Benson Hill Biosystems has already experienced so much growth that the Helix Center is in talks to double its capacity to accommodate it. Now, its recent $60M raise from Alphabet Inc.’s venture capital arm, GV, has further solidified the plant science firm’s reputation as a rising star in the field of crop innovation. Says Benson Hill CEO Matthew Crisp, the GV funding has “expanded our base of investors who recognize the power of plants and innovation to benefit both farmers and consumers.”
This article originally appeared in the St. Louis Post-Dispatch. View the rest of the article, here.